Compare Alcon AG (ALC) vs Bill.com Holdings Inc (BILL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Bill.com Holdings Inc — how do they compare? Alcon AG trades at $66.79 (market cap $32.69B), while Bill.com Holdings Inc trades at $39.58 (market cap $4.05B). The key difference: Alcon AG is far larger — about 8.1× Bill.com Holdings Inc's market cap, and Alcon AG pays a 0.54% dividend while Bill.com Holdings Inc pays none. Which is the better fit depends on your goals.
| ALC | BILL | |
|---|---|---|
Market Cap | $32.69B | $4.05B |
Sector | Health | Technology |
52-Week High | $92.22 | $56.32 |
52-Week Low | $62.02 | $31.96 |
Enterprise Value | $36.28B | $3.76B |
Dividend Yield | 0.54% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
BILL Holdings trades at $40.68, up 0.49% today, with strong analyst consensus pointing to a $48 price target. The stock shows bullish technical momentum with recent earnings beats and revenue growth from $1.3B to $1.46B in 2025. Recent executive appointments and AI focus signal strategic positioning for growth.
Outlook remains positive with 56% analyst buy ratings and 36% upside potential, though high P/E of 214 and thin net margins of 0.01% pose valuation risks. Key catalysts include continued earnings outperformance and AI integration, while macroeconomic sensitivity and competitive pressures require monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Bill.com Holdings Inc
Bill.com Holdings Inc is a provider of cloud-based software that simplifies, digitizes, and automates financial operations for SMBs. Its artificial-intelligence enabled financial software platform used mostly to build connections between customers, suppliers, and clients. The company's platform generates and process invoices, streamline approvals, send and receive payments, sync with their accounting system, and manage their cash. The firm generates revenue through subscription and transaction fees.
Read more on BILL →
